A case report on ayurvedic management of secondary amenorrhea DUE to polycystic ovarian syndrome
Abstract
Secondary amenorrhea is the absence of menstruation for a period of 6 months or longer in a woman with established normal cycles. Polycystic ovarian syndrome (PCOS) is one of the most common causes of pathological secondary amenorrhea. The diagnosis of polycystic ovarian syndrome is based on the presence of any 2 among the criteria: oligo and/or anovulation, hyperandrogenism, and polycystic ovaries. In Ayurveda, it can be considered Nashtartava. Modern management of PCOS is primarily focused on the use of hormonal preparations like oral contraceptive pills and insulin sensitizers like metformin. In cases resistant to medical therapy, laparoscopic ovarian drilling, and ovarian wedge resection surgeries are employed. The usage of contraceptive pills is associated with adverse effects like spotting or breakthrough bleeding (BTB), nausea, headache, breast tenderness, weight gain, mood changes, low libido, and dermatologic problems. This is a case report of a 24 year old unmarried woman with delayed menstrual cycles, last menstrual period 6 months back and increased facial hair growth, and mood swings for 6 years. On USG, she was diagnosed with PCOS. For this problem, she took allopathic medication twice. Despite having a few subsequent normal cycles, she developed symptoms including mood swings, headaches, excessive sweating, hair loss, and weight gain. She was forced to stop medications due to these problems which are the adverse effects of hormonal medications. She was…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.